Lazard Emerging Markets Equity Advantage Portfolio Q4 2024 Commentary

2025-03-19 11:30:00 ET

Summary

• During the quarter, the Lazard Emerging Markets Equity Advantage Portfolio outperformed the MSCI Emerging Markets Index (net of fees).
• As we look forward to 2025, we continue to believe that the bad news has been fully priced into the markets, which now trade at a 33% discount to their developed market counterparts.
• We remain positively disposed to the opportunities and outlook for emerging market equities in 2025.

Executive Summary

Read the full article on Seeking Alpha

For further details see: